Abstract
Atrial fibrillation (AF) and heart failure (HF) frequently coexist and complicate the course of treatment of each other. AF with rapid ventricular conduction can lead to tachycardia-mediated cardiomyopathy, which is a reversible cause of cardiomyopathy. However, in most cases, AF is the manifestation of various underlying cardiomyopathies. Guideline-directed pharmacological and device therapy for HF is essential. The management options for AF and HF include pharmacological rhythm control, pharmacological rate control, and interventional approaches, which include catheter ablation for AF via pulmonary vein isolation and atrioventricular node ablation. This is a contemporary review to discuss the available evidence regarding the various management approaches in this specific patient group.
Original language | English (US) |
---|---|
Pages (from-to) | 762-770 |
Number of pages | 9 |
Journal | Heart Rhythm O2 |
Volume | 2 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2021 |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine